Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203992
Max Phase: Preclinical
Molecular Formula: C39H37ClN6O7
Molecular Weight: 737.21
Associated Items:
ID: ALA5203992
Max Phase: Preclinical
Molecular Formula: C39H37ClN6O7
Molecular Weight: 737.21
Associated Items:
Canonical SMILES: CC1(C)[C@H](NC(=O)c2ccc3c(c2)C(=O)N(CCNc2cccc4c2C(=O)N(C2CCC(=O)NC2=O)C4=O)C3)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1
Standard InChI: InChI=1S/C39H37ClN6O7/c1-38(2)36(39(3,4)37(38)53-23-11-10-21(18-41)26(40)17-23)44-31(48)20-8-9-22-19-45(33(50)25(22)16-20)15-14-42-27-7-5-6-24-30(27)35(52)46(34(24)51)28-12-13-29(47)43-32(28)49/h5-11,16-17,28,36-37,42H,12-15,19H2,1-4H3,(H,44,48)(H,43,47,49)/t28?,36-,37-
Standard InChI Key: PZTVKFHYHJAYQQ-XUEBIDABSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 737.21 | Molecular Weight (Monoisotopic): 736.2412 | AlogP: 4.29 | #Rotatable Bonds: 9 |
Polar Surface Area: 178.01 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 13 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 11.59 | CX Basic pKa: 1.91 | CX LogP: 4.18 | CX LogD: 4.18 |
Aromatic Rings: 3 | Heavy Atoms: 53 | QED Weighted: 0.27 | Np Likeness Score: -0.59 |
1. Guo L, Zhou Y, Nie X, Zhang Z, Zhang Z, Li C, Wang T, Tang W.. (2022) A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions., 236 [PMID:35397401] [10.1016/j.ejmech.2022.114317] |
Source(1):